Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland

被引:0
作者
Marika Salminen
Marikka Kuoppamäki
Tero Vahlberg
Ismo Räihä
Kerttu Irjala
Sirkka-Liisa Kivelä
机构
[1] University of Turku,Institute of Clinical Medicine, Family Medicine
[2] Härkätie Health Centre,Unit of Family Medicine
[3] Turku University Hospital,Institute of Clinical Medicine, Biostatistics
[4] Naantali Health Centre,Department of Internal Medicine
[5] University of Turku,undefined
[6] Turku City Hospital,undefined
[7] Mehiläinen,undefined
[8] Satakunta Central Hospital,undefined
来源
Acta Diabetologica | 2011年 / 48卷
关键词
Metabolic syndrome; Vascular risk; Population-based study; Elderly; Aged;
D O I
暂无
中图分类号
学科分类号
摘要
The aim was to analyze the relationship between metabolic syndrome (MetS) and vascular risk among the aged. A prospective population-based study, with a 9-year follow-up. All subjects of the municipality of Lieto in Finland aged ≥64 in 1998–99 participated (n = 1183). Hazard ratios (HRs) for fatal or non-fatal coronary (CHD), cerebrovascular (CV), or all vascular events predicted by MetS (defined by International Diabetes Federation) were estimated. During the 9-year follow-up, a total of 348 vascular events occurred, including 208 CHD and 150 CV events. After multivariable adjustment, CHD events (1.70, 1.07–2.71, P = .026) and vascular events (1.57, 1.07–2.30, P = .021) were more common in men with MetS compared to men without it. Evaluating MetS components individually, low HDL-cholesterol among women predicted a higher occurrence of CV (2.44, 1.46–4.09, P < .001) and all vascular (1.78, 1.26–2.53, P = .001) events. Elevated blood pressure among men was related to fewer CHD events (0.46, 0.25–0.83, P = .010). Our findings suggest that MetS does predict vascular events in late life among men. In older women, only low HDL-cholesterol was associated with vascular risk. Slightly or moderately elevated blood pressure values do not predict vascular events in this age group.
引用
收藏
页码:157 / 165
页数:8
相关论文
共 167 条
[1]  
Eckel RH(2005)The metabolic syndrome Lancet 365 1415-1428
[2]  
Grundy SM(2004)Clinical importance of obesity versus metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) study Circulation 109 706-713
[3]  
Zimmet PZ(2004)Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women’s Ischemia Syndrome Evaluation Circulation 109 714-721
[4]  
Kip KE(2005)Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Diabetes Care 28 1463-1471
[5]  
Marroquin OC(2007)Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial Heart 93 1406-1411
[6]  
Kelley DE(2007)Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes Diabetes Care 30 1851-1856
[7]  
Marroquin OC(2007)Metabolic syndrome and risk of incident cardiovascular events and death J Am Coll Cardiol 49 403-414
[8]  
Kip KE(2007)The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects—a population-based study comparing three different definitions Diabet Med 24 464-472
[9]  
Kelley DE(2007)Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study Stroke 38 2063-2069
[10]  
Sone H(2007)The usefulness of the International Diabetes Federation and the national Cholesterol education Program’s Adult Treatment panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes Diabetes Care 30 1206-1211